{"id":"NCT00608322","sponsor":"National Institute of General Medical Sciences (NIGMS)","briefTitle":"Randomized Trial of Inhaled Nitric Oxide to Augment Tissue Perfusion in Sepsis","officialTitle":"Randomized Double-blind Placebo-controlled Trial of Inhaled Nitric Oxide for the Treatment of Microcirculatory Dysfunction and Organ Failure in Sepsis","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2009-08","primaryCompletion":"2013-04","completion":"2013-04","firstPosted":"2008-02-06","resultsPosted":"2013-07-11","lastUpdate":"2013-07-11"},"enrollment":49,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Sepsis"],"interventions":[{"type":"DRUG","name":"Inhaled nitric oxide","otherNames":["INOmax"]},{"type":"OTHER","name":"Sham inhaled nitric oxide","otherNames":[]}],"arms":[{"label":"1","type":"EXPERIMENTAL"},{"label":"2","type":"SHAM_COMPARATOR"}],"summary":"The purpose of this study is to determine whether inhaled nitric oxide is an effective treatment for microcirculatory dysfunction and acute organ system failure in the early stage of sepsis therapy.","primaryOutcome":{"measure":"Change in the Sequential Organ Failure Assessment (SOFA) Score","timeFrame":"0-24 hours from protocol initiation","effectByArm":[],"pValues":[]},"eligibility":{"minAge":"14 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":["17095120","15343008","11794169","25080051"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":9,"n":26},"commonTop":["Death"]}}